Source study found
Story checked
A low-calorie diet and exercise helped 54% of younger adults achieve diabetes remission (opens in a new tab)
news-medical.net · 2026-11-03
Short answer
Not assessedCheck incomplete.
We found a likely source study, but its evidence could not be prepared for claim review. The article's claims remain unverified.
Share this check
The story
A low-calorie diet and exercise helped 54% of younger adults achieve diabetes remission
news-medical.net · 2026-11-03
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Source study identified.
A source study was identified, but the study's evidence could not be prepared for claim assessment. No claim verdicts are available.
View article claimsThe source study
Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial
Evidence layer
Claim by claim
A source study was identified, but the study's evidence could not be prepared for claim assessment. The claims below have not been assessed.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedA clinical trial in Canada and the UK tested whether a low-energy diet plus supervised exercise could improve blood sugar control while protecting muscle health in younger adults with early-onset type 2 diabetes.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 2 of 5Not checkedThe study was a randomized, open-label, blinded-endpoint efficacy trial of low energy diet plus supervised exercise versus usual care alone in people with early-onset type 2 diabetes.View evidenceHide evidence
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 3 of 5Not checkedRemission occurred in 27 of 50 participants (54%) in the intervention group versus 2 of 46 (4%) in the control group over 24 weeks.View evidenceHide evidence
As stated54% vs 4%
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 4 of 5Not checkedAt 24 weeks, the intervention group lost 7.5 kilograms more than controls and had lower fat mass, while muscle volume and fat-free mass did not differ significantly between groups.View evidenceHide evidence
As stated7.5 kilograms more than controls; fat mass fell by 16.5% relative to controls
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Claim 5 of 5Not checkedThe article says no serious adverse events occurred, but adverse events were common in the intervention group.View evidenceHide evidence
As stated43 of 50 vs 6 of 46 reported at least one adverse event
Not checked
A source study was identified, but the evidence comparison for this claim was not completed. No verdict has been assigned.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial
The Lancet Regional Health - Americas · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
Crossref, Europe PMC, PubMed · 41 candidate papers
Low energy diet plus supervised exercise vs. usual care alone in people with early-onset type 2 diabetes (RESET for Remission): a randomised, open-label, blinded-endpoint efficacy trial
The Lancet Regional Health - Americas · 2026 · Crossref
Measles, mistrust, and missed protection in the Americas
The Lancet Regional Health - Americas · 2026 · Crossref
Phylodynamic analysis reveals asymmetric and accelerating global spread of dengue virus
2026 · Europe PMC
Medical AI in the Americas: policy, validation, and representativeness
The Lancet Regional Health - Americas · 2026 · Crossref
Food systems performance evaluated against targets and benchmarks reveals urgent gaps and a path to 2050.
2026 · Europe PMC
When recommendations meet reality: the challenge of walking in the Americas
The Lancet Regional Health - Americas · 2026 · Crossref
And 35 more candidates considered.